Endoluminal Suturing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, Others), By End User (Hospitals, Ambulatory Surgical Clinics, Others), By Region and By Competition, 2020-2030F

Market Overview

The Global Endoluminal Suturing Devices Market, valued at USD 85.65 Million in 2024, is projected to experience a CAGR of 11.91% to reach USD 168.21 Million by 2030. Endoluminal suturing devices are specialized medical instruments designed to facilitate the repair or sealing of internal tissues within the body, typically employed during minimally invasive endoscopic or laparoscopic procedures. These devices enable precise tissue approximation or plication, offering advantages such as reduced invasiveness and faster patient recovery. Market growth is primarily driven by the increasing global demand for minimally invasive surgeries, fueled by the rising prevalence of gastrointestinal disorders and obesity. According to the American Academy of Family Physicians, in 2023, one out of twelve people in the U. S. were diagnosed with gastric ulcers, illustrating a significant patient demographic requiring endoscopic interventions.

A significant challenge impeding market expansion is the scarcity of adequately skilled personnel, including surgeons and physicians, proficient in operating these intricate devices for complex endoluminal procedures. This shortage, coupled with the potential for complications from improper use, could restrict the volume of procedures performed, thereby limiting broader adoption. Additionally, the considerable initial investment costs for healthcare providers and inconsistencies in reimbursement policies further present hurdles to market penetration.

Key Market Drivers

The global market for endoluminal suturing devices is significantly propelled by two primary factors: the increasing adoption of minimally invasive surgical procedures and advancements in endoluminal suturing device technology. The growing preference for minimally invasive surgical procedures globally directly fuels demand for specialized tools like endoluminal suturing devices, which facilitate precise tissue approximation with reduced patient trauma and faster recovery times. This shift in surgical practice reflects both patient preference for less invasive options and healthcare provider recognition of their clinical and economic benefits. According to a 2025 article by the National Library of Medicine, in the U. S. , more than 50 million endoscopic procedures are performed annually, many of which can benefit from endoluminal suturing for tissue repair or defect closure.

Concurrent advancements in endoluminal suturing device technology further enhance the capabilities and adoption of these instruments. Innovations focus on improving device maneuverability, enhancing visualization, and enabling more complex tissue repair within the luminal environment, making these procedures safer and more effective. For example, according to Ambu, in September 2023, the company launched a larger-sized gastroscopy solution, the Ambu aBox 2 and Ambu aScope Gastro Large, following CE mark approval, expanding options for gastroscopy. The continuous evolution of these devices expands their application across a broader range of gastrointestinal and other luminal procedures. Overall, the increasing volume of endoscopic interventions creates a substantial opportunity for these specialized instruments; according to the World Gastroenterology Organization, in 2024, Helicobacter pylori remained a significant health concern, infecting more than half of the global population, often leading to conditions requiring endoscopic intervention.

Download Free Sample Report

Key Market Challenges

The scarcity of adequately skilled personnel, specifically surgeons and physicians proficient in complex endoluminal procedures, directly hampers the growth of the Global Endoluminal Suturing Devices Market. These specialized devices require extensive training and expertise to operate effectively and safely. A limited pool of such qualified medical professionals restricts the volume of advanced endoscopic interventions that can be performed, thereby slowing the adoption rate of these innovative suturing technologies. For instance, according to new projections published in March 2024 by the Association of American Medical Colleges, the United States is projected to face a physician shortage of up to 86,000 physicians by 2036. This broader shortage impacts the availability of specialists across various medical fields, including gastroenterology and advanced endoscopy, which directly utilize endoluminal suturing devices. The insufficient number of practitioners capable of utilizing these instruments means that despite the rising demand for minimally invasive surgeries, the market cannot expand to its full potential due to operational constraints imposed by the limited expert workforce.

Key Market Trends

The integration of robotic-assisted technologies represents a significant trend reshaping the Global Endoluminal Suturing Devices Market, enabling heightened precision and maneuverability in complex internal procedures. These systems extend surgeons' capabilities, facilitating intricate tissue manipulation and suturing within challenging anatomical spaces. According to the Royal Australasian College of Surgeons, in June 2023, robot-assisted surgeries performed on da Vinci platforms in Australia and Aotearoa New Zealand saw a 12 percent increase from 2021 to 2022, rising from 17,852 to 19,989 procedures. This growth underscores the expanding adoption and clinical confidence in robotic platforms. Further enhancing these capabilities, Intuitive Surgical introduced the da Vinci 5, a new robotic surgery platform in March 2024, which incorporated advanced 3D-HD imaging and Force Feedback technology to provide surgeons with tactile sensation during operations. Such innovations are critical for performing advanced endoluminal repairs more effectively, contributing to improved patient outcomes and reduced recovery times.

Another pivotal trend is the application of artificial intelligence and machine learning for enhancing procedural accuracy within endoluminal interventions. These advanced computational techniques process vast amounts of imaging data to assist in real-time decision-making, improve lesion detection, and optimize suturing placement. According to United European Gastroenterology, AI-supported tools have demonstrated the capacity to improve adenoma detection rates by almost 25%, highlighting their tangible impact on diagnostic quality. This statistical improvement is crucial for early detection and intervention, which directly influences the demand for precise suturing devices for subsequent repair. For example, Medtronic plc unveiled ColonPRO™ software for its GI Genius™ intelligent endoscopy system in April 2024, which featured an enhanced algorithm and resulted in a 9% reduction in false positives during polyp detection. This refined accuracy directly translates to more confident and precise endoluminal suturing applications, minimizing errors and improving overall procedural success.

Segmental Insights

The Bariatric Surgery segment is demonstrating rapid expansion within the Global Endoluminal Suturing Devices Market, primarily driven by the escalating global prevalence of obesity, which necessitates efficient weight management interventions. This growth is further propelled by the increasing demand for minimally invasive surgical techniques, where endoluminal suturing devices offer advantages such as reduced recovery times and fewer complications compared to traditional open surgeries. Additionally, continuous technological advancements in device design, enhancing precision and procedural efficacy for bariatric applications, contribute significantly to this segment's accelerated growth.

Regional Insights

North America consistently leads the Global Endoluminal Suturing Devices Market, primarily driven by its advanced and well-established healthcare infrastructure and a high adoption rate of innovative medical technologies. The region benefits from a significant prevalence of gastrointestinal and vascular disorders, coupled with a strong preference for minimally invasive surgical procedures, including bariatric and gastrointestinal surgeries, which directly increase the demand for these specialized devices. Furthermore, a favorable regulatory environment, notably influenced by the U. S. Food and Drug Administration (FDA) ensuring device safety and efficacy, alongside robust reimbursement policies, encourages market expansion and widespread utilization of endoluminal suturing devices. The presence of key market players and continuous investment in research and development further solidifies North America's dominant position.

Recent Developments

• In July 2025, Olympus Corporation established a strategic partnership with Revival Healthcare Capital, leading to the co-founding of Swan EndoSurgical. This new venture is committed to developing a novel endoluminal robotic system, backed by an initial combined investment of at least $65 million. The collaboration aims to transform gastrointestinal patient care by enabling physicians to perform innovative and safe minimally invasive techniques. This partnership exemplifies a focused collaboration and breakthrough research initiative within the endoluminal robotics segment, promising advancements in surgical precision and patient outcomes.

• In April 2025, Johnson & Johnson Inc. announced the successful completion of the initial surgical cases within its clinical trial for the OTTAVA Robotic Surgical System. This milestone marks the first clinical deployment of the system, which features four robotic arms integrated into a surgical table, designed for improved flexibility in the operating room. While the system supports various surgical applications, its use is expected to advance endoluminal suturing capabilities within minimally invasive procedures. This development underscores Johnson & Johnson’s ongoing breakthrough research in robotic-assisted surgical platforms relevant to endoluminal applications.

• In November 2024, Medtronic completed the acquisition of Fortimedix Surgical, a company known for its expertise in developing flexible articulating instruments. These instruments are designed to facilitate endoscopic and other minimally invasive procedures by allowing navigation through intricate anatomical structures. This acquisition strategically enhances Medtronic's offerings in the global endoluminal suturing devices market by incorporating advanced instrumentation that supports precise internal tissue approximation without requiring external incisions. The move reinforces Medtronic's commitment to advancing minimally invasive surgical technologies.

• In September 2024, Boston Scientific's symposium at Florida Live Endoscopy 2024 showcased the next-generation OverStitch NXT suturing device. This advanced system, integrating technology from Apollo Endosurgery, offers enhanced articulation for navigating challenging gastric angles. It facilitates improved procedural techniques, such as interlocking endoscopic sleeve gastroplasty, which creates more robust tissue plications for effective weight management. This represents a significant product launch in the global endoluminal suturing devices market, broadening the scope and precision of endoscopic gastrointestinal interventions.

Key Market Players

• Apollo Endosurgery, Inc.
• Johnson & Johnson
• Medtronic Plc
• Cook Group Incorporated
• USGI Medical, Inc.
• Ovesco Endoscopy AG
• Endo Tools Therapeutics S.A.
• ErgoSuture Corp.
• Sutrue Ltd.

Report Scope:

In this report, the Global Endoluminal Suturing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Endoluminal Suturing Devices Market, By Application:

o   Bariatric Surgery

o   Gastrointestinal Surgery

o   Gastroesophageal Reflux Disease Surgery

o   Others

• Endoluminal Suturing Devices Market, By End User:

o   Hospitals

o   Ambulatory Surgical Clinics

o   Others

• Endoluminal Suturing Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Endoluminal Suturing Devices Market.

Available Customizations:

Global Endoluminal Suturing Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Endoluminal Suturing Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]